{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:11:58Z","timestamp":1791090718251,"version":"4.1.0"},"reference-count":32,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7,1]]},"DOI":"10.1210\/me.2010-0400","type":"journal-article","created":{"date-parts":[[2011,5,14]],"date-time":"2011-05-14T00:14:10Z","timestamp":1305332050000},"page":"1244-1253","source":"Crossref","is-referenced-by-count":37,"title":["Research Resource: Haploinsufficiency of Receptor Activity-Modifying Protein-2 (Ramp2) Causes Reduced Fertility, Hyperprolactinemia, Skeletal Abnormalities, and Endocrine Dysfunction in Mice"],"prefix":"10.1210","volume":"25","author":[{"given":"Mahita","family":"Kadmiel","sequence":"first","affiliation":[{"name":"Department of Cell and Molecular Physiology (M.K., K.F.-S., M.L., K.M.C.), The University of North Carolina, Chapel Hill, North Carolina 27599;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Fritz-Six","sequence":"additional","affiliation":[{"name":"Department of Cell and Molecular Physiology (M.K., K.F.-S., M.L., K.M.C.), The University of North Carolina, Chapel Hill, North Carolina 27599;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suruchi","family":"Pacharne","sequence":"additional","affiliation":[{"name":"Academic Unit of Bone Biology (S.P., G.O.R., T.M.S.), Section of Musculoskeletal Science, School of Medicine and Biomedical Sciences, Beech Hill Road, Sheffield S10 2RX, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth O.","family":"Richards","sequence":"additional","affiliation":[{"name":"Academic Unit of Bone Biology (S.P., G.O.R., T.M.S.), Section of Musculoskeletal Science, School of Medicine and Biomedical Sciences, Beech Hill Road, Sheffield S10 2RX, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manyu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cell and Molecular Physiology (M.K., K.F.-S., M.L., K.M.C.), The University of North Carolina, Chapel Hill, North Carolina 27599;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim M.","family":"Skerry","sequence":"additional","affiliation":[{"name":"Academic Unit of Bone Biology (S.P., G.O.R., T.M.S.), Section of Musculoskeletal Science, School of Medicine and Biomedical Sciences, Beech Hill Road, Sheffield S10 2RX, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Caron","sequence":"additional","affiliation":[{"name":"Department of Cell and Molecular Physiology (M.K., K.F.-S., M.L., K.M.C.), The University of North Carolina, Chapel Hill, North Carolina 27599;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041122072181900_B1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1196\/annals.1317.076","article-title":"Complexing receptor pharmacology: modulation of family B G protein-coupled receptor function by RAMPs.","volume":"1070","author":"Sexton","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"2019041122072181900_B2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/30666","article-title":"RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature"},{"key":"2019041122072181900_B3","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa030505","article-title":"Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.","volume":"350","author":"Olesen","year":"2004","journal-title":"N Engl J Med"},{"key":"2019041122072181900_B4","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(08)61626-8","article-title":"Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.","volume":"372","author":"Ho","year":"2008","journal-title":"Lancet"},{"key":"2019041122072181900_B5","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1212\/01.WNL.0000286940.29755.61","article-title":"Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine.","volume":"70","author":"Ho","year":"2008","journal-title":"Neurology"},{"key":"2019041122072181900_B6","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1021\/jm070668p","article-title":"Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine: discovery of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin- 1-yl)piperidine-1-carboxamide (MK-0974).","volume":"50","author":"Paone","year":"2007","journal-title":"J Med Chem"},{"key":"2019041122072181900_B7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1124\/jpet.109.163816","article-title":"Pharmacological properties of MK-3207, a potent and orally active calcitonin gene-related peptide receptor antagonist.","volume":"333","author":"Salvatore","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"2019041122072181900_B8","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1074\/jbc.C200629200","article-title":"Novel receptor partners and function of receptor activity-modifying proteins.","volume":"278","author":"Christopoulos","year":"2003","journal-title":"J Biol Chem"},{"key":"2019041122072181900_B9","doi-asserted-by":"crossref","first-page":"11773","DOI":"10.1021\/bi901326k","article-title":"Molecular basis of association of receptor activity-modifying protein 3 with the family B G protein-coupled secretin receptor.","volume":"48","author":"Harikumar","year":"2009","journal-title":"Biochemistry"},{"key":"2019041122072181900_B10","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1242\/jcs.02598","article-title":"Receptor-activity-modifying proteins are required for forward trafficking of the calcium-sensing receptor to the plasma membrane.","volume":"118","author":"Bouschet","year":"2005","journal-title":"J Cell Sci"},{"key":"2019041122072181900_B11","volume-title":"Understanding RAMPs through genetically engineered mouse models","author":"Kadmiel","year":"2010"},{"key":"2019041122072181900_B12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1172\/JCI33302","article-title":"Adrenomedullin signaling is necessary for murine lymphatic vascular development.","volume":"118","author":"Fritz-Six","year":"2008","journal-title":"J Clin Invest"},{"key":"2019041122072181900_B13","doi-asserted-by":"crossref","first-page":"18094","DOI":"10.1074\/jbc.M703544200","article-title":"Receptor activity-modifying proteins 2 and 3 have distinct physiological functions from embryogenesis to old age.","volume":"282","author":"Dackor","year":"2007","journal-title":"J Biol Chem"},{"key":"2019041122072181900_B14","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1172\/JCI28462","article-title":"Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice.","volume":"116","author":"Li","year":"2006","journal-title":"J Clin Invest"},{"key":"2019041122072181900_B15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2826.2008.01661.x","article-title":"Pregnancy-induced adaptation in the neuroendocrine control of prolactin secretion.","volume":"20","author":"Grattan","year":"2008","journal-title":"J Neuroendocrinol"},{"key":"2019041122072181900_B16","volume-title":"Statistical methods, experimental design, and scientific inference","author":"Fisher","year":"1972","edition":"14th ed."},{"key":"2019041122072181900_B17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1073\/pnas.98.2.615","article-title":"Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene.","volume":"98","author":"Caron","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122072181900_B18","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1128\/MCB.26.7.2511-2518.2006","article-title":"Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the calcitonin receptor-like receptor gene.","volume":"26","author":"Dackor","year":"2006","journal-title":"Mol Cell Biol"},{"key":"2019041122072181900_B19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1432-0436.2005.00013.x","article-title":"PTHrP promotes murine secondary trophoblast giant cell differentiation through induction of endocycle, upregulation of giant-cell-promoting transcription factors and suppression of other trophoblast cell types.","volume":"73","author":"El-Hashash","year":"2005","journal-title":"Differentiation"},{"key":"2019041122072181900_B20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ydbio.2005.10.010","article-title":"PTHrP induces changes in cell cytoskeleton and E-cadherin and regulates Eph\/Ephrin kinases and RhoGTPases in murine secondary trophoblast cells.","volume":"290","author":"El-Hashash","year":"2006","journal-title":"Dev Biol"},{"key":"2019041122072181900_B21","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1242\/dev.121.11.3539","article-title":"Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development.","volume":"121","author":"Wysolmerski","year":"1995","journal-title":"Development"},{"key":"2019041122072181900_B22","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1242\/dev.125.7.1285","article-title":"Rescue of the parathyroid hormone-related protein knockout mouse demonstrates that parathyroid hormone-related protein is essential for mammary gland development.","volume":"125","author":"Wysolmerski","year":"1998","journal-title":"Development"},{"key":"2019041122072181900_B23","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1083\/jcb.126.6.1611","article-title":"Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation.","volume":"126","author":"Amizuka","year":"1994","journal-title":"J Cell Biol"},{"key":"2019041122072181900_B24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1006\/dbio.1996.0104","article-title":"Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development.","volume":"175","author":"Amizuka","year":"1996","journal-title":"Dev Biol"},{"key":"2019041122072181900_B25","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2174\/1381612013397753","article-title":"PTHrP: novel roles in skeletal biology.","volume":"7","author":"Karaplis","year":"2001","journal-title":"Curr Pharm Des"},{"key":"2019041122072181900_B26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1172\/JCI6629","article-title":"Ablation of the PTHrP gene or the PTH\/PTHrP receptor gene leads to distinct abnormalities in bone development.","volume":"104","author":"Lanske","year":"1999","journal-title":"J Clin Invest"},{"key":"2019041122072181900_B27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ydbio.2005.12.044","article-title":"PTH\/PTHrP receptor delays chondrocyte hypertrophy via both Runx2-dependent and -independent pathways.","volume":"292","author":"Guo","year":"2006","journal-title":"Dev Biol"},{"key":"2019041122072181900_B28","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1210\/en.2005-1410","article-title":"Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturation.","volume":"147","author":"Vuguin","year":"2006","journal-title":"Endocrinology"},{"key":"2019041122072181900_B29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1083\/jcb.200312135","article-title":"Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo.","volume":"164","author":"Dacquin","year":"2004","journal-title":"J Cell Biol"},{"key":"2019041122072181900_B30","first-page":"E1113","article-title":"Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo.","volume":"273","author":"Cornish","year":"1997","journal-title":"Am J Physiol"},{"key":"2019041122072181900_B31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method.","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"2019041122072181900_B32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1469-7580.2007.00698.x","article-title":"Absence of mechanical loading in utero influences bone mass and architecture but not innervation in Myod-Myf5-deficient mice.","volume":"210","author":"Gomez","year":"2007","journal-title":"J Anat"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/25\/7\/1244\/8932970\/mend1244.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T07:04:37Z","timestamp":1637651077000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/25\/7\/1244\/2614759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,1]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/me.2010-0400","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,1]]}}}